I now have comprehensive information from Barash's Clinical Anesthesia (a complete dedicated chapter on MAC). I have enough content to write a thorough 10-mark answer. Let me compile it now.
Monitored Anaesthesia Care (MAC)
Based on Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, Chapter 30
Definition and Terminology
Monitored Anaesthesia Care (MAC) is a specific anesthesia service in which a qualified anesthesiologist is requested to participate in the care of a patient undergoing a diagnostic or therapeutic procedure. It encompasses all the usual aspects of anaesthetic care - a pre-procedure evaluation, intraprocedure care, and postprocedure management.
MAC does not describe a fixed depth of sedation. It implies the potential for a broader range of analgesia and sedation than can be provided by moderate sedation, including the potential conversion to a general or regional anaesthetic.
The ASA (October 2018) distinguishes MAC from "moderate sedation/analgesia":
- MAC - provided by a qualified anesthesiologist; may span the full spectrum from light anxiolysis to general anaesthesia
- Moderate sedation/analgesia ("conscious sedation") - may be provided by non-anesthesiologist providers and should NOT intend to attain a level where the patient is unresponsive
Key principle: If the patient loses consciousness and the ability to respond purposefully, the anaesthesia care is a general anaesthetic, irrespective of whether airway instrumentation is required.
Indications
MAC is indicated when:
- The nature of the procedure warrants it (e.g., cataract surgery, colonoscopy, bronchoscopy, cardiac catheterization, minor dermatologic procedures)
- The patient's clinical condition necessitates an anesthesiologist (e.g., extremes of age, hemodynamic instability, psychiatric disorders, morbid obesity)
- A deeper level of analgesia/sedation is required than non-anesthesiologist providers can safely offer
- The patient requests or requires supplementation to local/regional anaesthesia
Preoperative Assessment
Standards are identical to those for general or regional anaesthesia and include:
- Medical status: Full history, physical, comorbidities (airway, cardiovascular, respiratory)
- Airway evaluation: The Mallampati score, mouth opening, neck mobility - because MAC can convert to general anaesthesia at any moment, a difficult airway plan is mandatory
- MAC candidacy: Patient ability to remain cooperative; psychological factors (claustrophobia, severe anxiety, dementia may make MAC impractical)
- Patient expectations: Must be counselled that awareness is possible and intentional during MAC
ASA Continuum of Sedation Depth
| Level | Responsiveness | Airway | Spontaneous Ventilation | CV Function |
|---|
| Minimal sedation (anxiolysis) | Normal to verbal | Unaffected | Unaffected | Unaffected |
| Moderate sedation ("conscious sedation") | Purposeful to verbal/tactile | No intervention needed | Adequate | Usually maintained |
| Deep sedation | Purposeful to repeated/painful stimulation | May need intervention | May be inadequate | Usually maintained |
| General anaesthesia | Unarousable | Intervention often needed | Often inadequate | May be impaired |
Monitoring Standards during MAC
ASA standards for monitoring during MAC are identical to those for general anaesthesia:
- Pulse oximetry - continuous; gives early warning of respiratory depression
- Capnography (ETCO2) - increasingly recognized as the most sensitive and earliest indicator of respiratory depression; recommended alongside supplemental oxygen via modified face masks that allow CO2 sampling
- ECG - continuously displayed
- Non-invasive blood pressure - recorded at minimum every 5 minutes
- Temperature - when clinically significant changes are anticipated; MAC is associated with inadvertent hypothermia especially at extremes of age and with neuraxial techniques
- Depth of sedation monitoring:
- Clinical: Ramsay Sedation Scale, Richmond Agitation-Sedation Scale (RASS), Observers' Assessment of Alertness/Sedation (OAA/S) scale
- Electronic: Bispectral Index (BIS) or patient state index (PSI) using processed EEG; useful adjuncts but not substitutes for clinical assessment
- Communication and observation - the anesthesiologist's continuous presence and attention remain the most important monitoring tool
Supplemental Oxygen and Fire Risk
Supplemental O2 should be administered during MAC. However, the use of O2 in the head and neck region creates a fire hazard:
- The combination of electrocautery + supplemental O2 + alcohol prep + flammable drapes is particularly dangerous
- Burns around the head and neck are an important cause of morbidity during MAC
- Risk mitigation: use lowest possible FiO2, allow 1 minute drying of alcohol preps, tent drapes to prevent O2 pooling
Pharmacology of MAC
Key principle: No single drug provides all components of MAC (analgesia, anxiolysis, hypnosis) with an acceptable safety margin. A multimodal, titrated approach is used.
Propofol
- Most commonly used drug for MAC
- Advantages: rapid onset, short context-sensitive half-time, antiemetic properties, smooth sedation
- Infusion rates: 25-75 mcg/kg/min for sedation
- Disadvantages: pain on injection, respiratory depression (apnoea with boluses), no analgesic properties, hypotension
Benzodiazepines
- Midazolam most commonly used: 0.5-2 mg IV titrated
- Provides anxiolysis, amnesia; does NOT provide analgesia
- Synergistic with opioids and propofol (significant respiratory depression risk)
- Long context-sensitive half-time makes recovery slower than propofol
Opioids
- Fentanyl, remifentanil, and alfentanil used
- Provide analgesia and sedation; potentiate other agents
- Remifentanil: ultra-short context-sensitive half-time; ideal for brief painful stimuli; risk of rapid tolerance
- Context-sensitive half-time concept: for infusions >8 hours, sufentanil's context-sensitive half-time is less than alfentanil's despite alfentanil's shorter elimination half-life
Ketamine
- Dissociative anaesthetic with analgesic, sedative, and amnestic properties
- Preserves airway reflexes and spontaneous ventilation
- Maintains or increases hemodynamic parameters
- Side effects: emergence reactions, increased secretions, nausea
- Combined with a benzodiazepine or low-dose propofol to reduce dysphoria
"Ketofol" (Ketamine + Propofol combination)
- The analgesic effect of ketamine reduces propofol requirements
- Advantages: hemodynamic stability, decreased PONV, improved procedural conditions, decreased airway complications
- Ratios range from 1:1 to 1:10 (ketamine:propofol)
- Dosing follows propofol: 0.25 mg/kg bolus, then infusion at 25-50 mcg/kg/min or incremental boluses of 0.25-0.5 mg/kg every 3-5 minutes
Dexmedetomidine
- Selective α2-agonist: sedation, analgesia, anxiolysis with minimal respiratory depression
- Produces a "cooperative sedation" - patients are calm but arousable
- Potentiates opioid analgesia and benzodiazepine hypnosis
- Loading dose: 1 mcg/kg over 10 minutes; maintenance: 0.2-0.7 mcg/kg/hour
- Side effects: bradycardia, hypotension
Complications
1. Respiratory Depression
- The leading cause of death and serious CNS injury during MAC is hypoxia from suppression of spontaneous respiration by sedative-hypnotic drugs
- Risk factors: elderly, obese, OSA, opioid-sedative combinations
- Management: reduce/stop infusions, jaw thrust, supplemental O2, airway adjuncts, bag-mask ventilation, naloxone/flumazenil if needed
2. Aspiration
- Risk increased with sedation as laryngeal reflexes may be blunted
- Pre-procedure fasting (NPO) guidelines apply equally to MAC patients
3. Laryngospasm
- Can occur if protective airway reflexes are stimulated during deep sedation
- Management: continuous positive airway pressure, deepen anaesthesia, succinylcholine if severe
4. Cardiovascular Complications
- Hemodynamic instability from vasodilation (propofol), vagal stimulation, or patient's underlying disease
5. Local Anaesthetic Systemic Toxicity (LAST)
- Must be prepared to recognize and treat LAST when MAC is provided alongside local/regional techniques
- Treatment: stop injection, 20% lipid emulsion, airway management, benzodiazepines for seizures
6. Fire/Burns
- As above; vigilance required with O2 and electrocautery in head/neck region
Conversion to General Anaesthesia
The qualified MAC provider must be prepared at all times to convert to general anaesthesia. Indications:
- Patient movement during a critical step
- Patient uncooperativeness
- Excessive sedation requiring airway instrumentation
- Surgical complications requiring deeper anaesthesia
- Hemodynamic deterioration
Medicolegal and Closed Claims Considerations
- MAC closed claims are associated with death and severe brain damage
- Most adverse outcomes involved respiratory depression from oversedation
- Documentation of appropriate pre-procedural assessment, intra-procedural monitoring, and post-procedure care is legally important
- MAC providers are held to the same standard of care as general anaesthesia
Future Directions
- Patient-controlled sedation/analgesia (PCS): Patient self-titrates sedation (e.g., propofol via lockout device)
- Target-controlled infusions (TCI): Pharmacokinetic models (Marsh, Schnider) drive pumps to achieve desired plasma or effect-site concentrations
- Closed-loop anaesthesia delivery systems: BIS or other EEG biomarkers used as real-time feedback to automate sedation delivery
Summary Points for Exam
- MAC = anesthesiologist-provided service; spans full sedation spectrum including potential conversion to GA
- Standards of preoperative evaluation and monitoring = identical to GA
- No single drug is ideal; multimodal titrated approach preferred
- Leading cause of serious injury = respiratory depression/hypoxia
- Supplemental O2 + electrocautery = fire risk (especially head/neck)
- Convert to GA promptly if patient loses purposeful responsiveness
- Capnography is the most sensitive early monitor for respiratory depression
- Dexmedetomidine = least respiratory depression; "cooperative sedation"
- Remifentanil = ultrashort context-sensitive half-time; ideal for brief stimuli
- MAC closed claims: mostly respiratory, mostly preventable
Sources: Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e - Chapter 30 (Monitored Anesthesia Care); Miller's Anesthesia, 10e